Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athol Wells

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 31, 2023
A rare case of extensive biventricular cardiac sarcoidosis with reversible torrential tricuspid regurgitationJoseph Okafor, Alessia Azzu, Raheel Ahmed, et al.
Scientific Reports|April 4, 2019
Mitochondrial DNA mutations and respiratory chain dysfunction in idiopathic and connective tissue disease-related lung fibrosisVeronika K Jaeger, Dirk Lebrecht, Andrew G Nicholson, et al.
JACC. Cardiovascular Imaging|March 24, 2017
Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac SarcoidosisVasileios Kouranos, George E Tzelepis, Aggeliki Rapti, et al.
American Journal of Respiratory and Critical Care Medicine|August 24, 2019
Before Freezing Out Cryobiopsy, We Need to Thaw Out Flaws in the Diagnosis of Interstitial Lung DiseaseFabien Maldonado, Athol Wells, Sonye Danoff, et al.
Health Technology Assessment (Winchester, England)|March 12, 2015
The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluationEmma Loveman, Vicky R Copley, Jill Colquitt, et al.
Journal of Pain and Symptom Management|July 1, 2014
Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trialJulia Riley, Ruth Branford, Joanne Droney, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 13, 2024
Role of serial <sup>18</sup>F-fludeoxyglucose positron emission tomography in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosisJoseph Okafor, Rajdeep Khattar, Vasileios Kouranos, et al.
Frontiers in Medicine|June 19, 2023
Historical eye on IPF: a cohort study redefining the mortality scenarioSara Tomassetti, Claudia Ravaglia, Sara Piciucchi, et al.
BMC Pharmacology & Toxicology|November 21, 2014
The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluationEmma Loveman, Vicky R Copley, Jill L Colquitt, et al.
Echo Research and Practice|April 26, 2026
Evaluation of contemporary echocardiography for the detection of cardiac sarcoidosisJoseph Okafor, Alessia Azzu, Raheel Ahmed, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|May 31, 2023
A rare case of extensive biventricular cardiac sarcoidosis with reversible torrential tricuspid regurgitationJoseph Okafor, Alessia Azzu, Raheel Ahmed, et al.
Scientific Reports|April 4, 2019
Mitochondrial DNA mutations and respiratory chain dysfunction in idiopathic and connective tissue disease-related lung fibrosisVeronika K Jaeger, Dirk Lebrecht, Andrew G Nicholson, et al.
JACC. Cardiovascular Imaging|March 24, 2017
Complementary Role of CMR to Conventional Screening in the Diagnosis and Prognosis of Cardiac SarcoidosisVasileios Kouranos, George E Tzelepis, Aggeliki Rapti, et al.
American Journal of Respiratory and Critical Care Medicine|August 24, 2019
Before Freezing Out Cryobiopsy, We Need to Thaw Out Flaws in the Diagnosis of Interstitial Lung DiseaseFabien Maldonado, Athol Wells, Sonye Danoff, et al.
Health Technology Assessment (Winchester, England)|March 12, 2015
The clinical effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: a systematic review and economic evaluationEmma Loveman, Vicky R Copley, Jill Colquitt, et al.
Journal of Pain and Symptom Management|July 1, 2014
Morphine or oxycodone for cancer-related pain? A randomized, open-label, controlled trialJulia Riley, Ruth Branford, Joanne Droney, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|March 13, 2024
Role of serial <sup>18</sup>F-fludeoxyglucose positron emission tomography in determining the therapeutic efficacy of immunosuppression and clinical outcome in patients with cardiac sarcoidosisJoseph Okafor, Rajdeep Khattar, Vasileios Kouranos, et al.
Frontiers in Medicine|June 19, 2023
Historical eye on IPF: a cohort study redefining the mortality scenarioSara Tomassetti, Claudia Ravaglia, Sara Piciucchi, et al.
BMC Pharmacology & Toxicology|November 21, 2014
The effectiveness and cost-effectiveness of treatments for idiopathic pulmonary fibrosis: systematic review, network meta-analysis and health economic evaluationEmma Loveman, Vicky R Copley, Jill L Colquitt, et al.
Echo Research and Practice|April 26, 2026
Evaluation of contemporary echocardiography for the detection of cardiac sarcoidosisJoseph Okafor, Alessia Azzu, Raheel Ahmed, et al.
Pageof 7